

Corner Office Conversation with The New Leaders of Indian Pharma
Aug 4, 2025
Sharvil Patel, Managing Director of Zydus Lifesciences, joins industry leaders to discuss India's transformative journey from a generics powerhouse to an innovation-driven biotech sector. They tackle the challenges of regulatory environments and pricing pressures while sharing insights on the importance of a robust R&D ecosystem. Patel emphasizes Zydus’ research-focused initiatives, while Namita Thapar highlights women's health advocacy, and Aman Mehta talks about shifting to a patient-centric approach. The conversation poses a vital question: Can India evolve from the 'pharmacy of the world' to its 'laboratory'?
AI Snips
Chapters
Transcript
Episode notes
India’s Global Pharma Leadership
- India is a global leader providing affordable generic medicines, with 1 in every 2 pills in the US made in India.
- This role underpins India's responsibility to improve healthcare access worldwide.
Harness Tech to Fix Healthcare
- Apply technology to solve awareness, access, and affordability issues in Indian healthcare.
- Collaborate legacy pharma players with startups to transform the healthcare ecosystem.
Innovation Beyond Generics
- The barriers to generic drug market entry are lowering, increasing competition.
- Investing in discovery and rare diseases can create unique impact and growth opportunities.